Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability

The present IIT (Investigator-Initiated Trial) study is a prospective, single-group, pre-post study (phase IV). A past study showed that among Anthroposophical physicians the most frequent diagnosis group where BP preparations are prescribed are mental and behavioural disorders such as anxiety and sleep disorders. In the present study, we, therefore, want to investigate the effectiveness of Bryophyllum tablets in patients with anxiety symptoms. Study participants will be recruited among the patients on the waiting list of the Department of Psychiatry and Psychosomatics at the Clinic Arlesheim. * Participant recruitment will continue until 60 patients have concluded the study. * Recruitment period will probably last 15 months. * Duration of the drug administration is 3 weeks. Participants will fill in a questionnaire three times. At baseline, after two and after three weeks of Bryophyllum intake.